We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Loses Bid To End Wyeth ReFacto Patent Suit

Law360 (May 7, 2009, 12:00 AM EDT) -- Novartis AG has failed to have claims against it dismissed or transferred in an ongoing battle with Wyeth subsidiary Genetics Institute over who legally owns the formula for ReFacto, a drug...
To view the full article, register now.